cbdMD
(AMEX:YCBD)
$0.90
-0.0467[-4.93%]
Last update: 1:26PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

cbdMD Stock (AMEX:YCBD), Quotes and News Summary

cbdMD Stock (AMEX: YCBD) stock price, news, charts, stock research, profile.

Open$0.948
Close-
Volume / Avg.29.564K / 260.787K
Day Range0.880 - 0.948
52 Wk Range0.560 - 8.055
Market Cap$2.741M
P/E Ratio-
Dividend Yield-
ExchangeAMEX
RSI
53
Short Interest
13.95%
Days to Cover1

Recent News

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets
Medical cannabis company cbdMD has reported financial results for its first quarter of fiscal 2024. Operating loss improved to $1.1m compared to $4.1m for the same period in the previous year. Gross profit was flat at around $3.5m, while operating expenses were $4.6m, down from $7.6m in the previous year. Total net sales declined to $5.37m from almost $6m in the corresponding prior-year period. Direct-to-consumer net sales represented 82.3% of total net sales, a decrease from 90% in Q1 2023. On 31 December 2023, cbdMD had total working capital of roughly $1.4m compared to approximately $3.4m on 30 September, with cash on hand dropping to roughly $1.5m from $1.8m over the same period. The Charlotte-based company recently struck a securities purchase agreement with five institutional investors to fund the national rollout of its ATRx Labs functional mushroom products, as well as launching the hempMD and ATRx Labs brands.
Jelena Martinovic
Medical Cannabis Pioneer cbdMD Secures $1.2M To Fund Rollout Of Functional Mushroom Products
Medical cannabis producer cbdMD has secured $1.25m in financing from five institutional investors to support the national rollout of its new ATRx Labs functional mushroom products. North Carolina-based cbdMD will use the proceeds for working capital as well. The news comes after the company launched two new products--Apple Cider Vinegar (ACV) and Immunity Gummy Pouches-through grocery chain Sprouts Farmers Market. Sprouts chose cbdMD to be a leading brand in its CBD section. The institutional investors will receive a senior secured original issue discount convertible promissory note, which matures 18 months from the date of issue. At that point, the notes can be converted into shares at a rate of $0.684 per share.
Jelena Martinovic
Medical Cannabis Co. Expands Into National Grocery Chain: cbdMD's Gummies Hit Shelves At Sprouts Farmers Market
cbdMD, Inc., a medical cannabis company, has entered into a partnership with Sprouts Farmers Market to make its Apple Cider Vinegar (ACV) and Immunity Gummy Pouches available in 175 locations nationwide. Sprouts Farmers Market has chosen cbdMD as a prominent brand for its CBD section. Shannon Charles, CMO at cbdMD, expressed their gratitude for this opportunity and their dedication to quality and customer satisfaction. The ACV Gummies contain organic apple cider vinegar powder and provide daily Vitamin B12 and Folic Acid requirements, while the Immunity Gummies support immune health with essential vitamins and antioxidants. The gummies are vegan-friendly, gluten-free, and compliant with the Farm Bill. Charles stated that this partnership brings them closer to their goal of promoting a balanced lifestyle and optimal wellness.
Jelena Martinovic
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About cbdMD Inc
Sector
Health Care
Industry
Pharmaceuticals
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
YCBD
CING

FAQ

Q

How do I buy cbdMD (YCBD) stock?

A

You can purchase shares of cbdMD (AMEX: YCBD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are cbdMD's (YCBD) competitors?

A

Other companies in cbdMD’s space includes: Cingulate (NASDAQ:CING), Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).

Q

What is the target price for cbdMD (YCBD) stock?

A

The latest price target for cbdMD (AMEX: YCBD) was reported by Maxim Group on Thursday, October 5, 2023. The analyst firm set a price target for 3.00 expecting YCBD to rise to within 12 months (a possible 233.33% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for cbdMD (YCBD)?

A

The stock price for cbdMD (AMEX: YCBD) is $0.9 last updated Today at April 16, 2024 at 1:26 PM EDT.

Q

Does cbdMD (YCBD) pay a dividend?

A

There are no upcoming dividends for cbdMD.

Q

When is cbdMD (AMEX:YCBD) reporting earnings?

A

cbdMD’s Q2 earnings are confirmed for Monday, May 13, 2024.

Q

Is cbdMD (YCBD) going to split?

A

There is no upcoming split for cbdMD.

Q

What sector and industry does cbdMD (YCBD) operate in?

A

cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

People Also Watch